Brenus Pharma

Brenus Pharma develops anti-cancer vaccines, such as STC-1010 targeting metastatic colorectal cancer, using a proteomics-guided cellular immunotherapy approach. This innovative method educates the patient's immune system to recognize and target tumor resistance mechanisms. The company aims to finalize STC-1010 development, bioproduction, and conduct clinical trials.

Buy Funded Startups lists

Funding Round: Grant

Funding Amount: €5M

Date: 22-Jan-2024

Investors: France 2030, Bpifrance

Markets: Biotechnology, Oncology, Immunotherapy

HQ: Lyon, Auvergne-Rhône-Alpes, France

Founded: 2014

Website: https://www.brenus-pharma.com/

LinkedIn: https://www.linkedin.com/company/brenus-pharma/

Twitter: https://twitter.com/BrenusP

Instagram: